Showing results (1061-1070 of 1,171) with videos related to
Sort By:
Pageof 118
International Journal of Biological Macromolecules|July 29, 2024
Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammationXiu-Tao Fu, Jing-Bo Qie, Jia-Feng Chen, et al.Cancer Immunology, Immunotherapy : CII|May 10, 2024
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket studyShengxiang Ren, Anwen Xiong, Jia Yu, et al.Journal of Hepatology|March 20, 2018
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinomaLiang-Qing Dong, Yang Shi, Li-Jie Ma, et al.Surgical Endoscopy|September 8, 2022
Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysisDan-Jun Song, Kai Zhu, Jin-Peng Tan, et al.Journal of Biomedical Optics|July 22, 2024
Exploring near-infrared autofluorescence properties in parathyroid tissue: an analysis of fresh and paraffin-embedded thyroidectomy specimensBo Wang, Chi-Peng Zhou, Wei Ao, et al.Science China. Life Sciences|February 9, 2018
42,573 cases of hepatectomy in China: a multicenter retrospective investigationBinhao Zhang, Bixiang Zhang, Zhiwei Zhang, et al.Clinical and Translational Medicine|May 18, 2026
A multi-centre, prospective trial of a methylation-based liquid biopsy for early detection of liver cancer in high-risk populationsRuohan Zhang, Xinrong Yang, Guangming Li, et al.Oncotarget|July 24, 2015
miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinomaLuqing Zhao, Min Tang, Zheyu Hu, et al.Hepatology International|November 18, 2023
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancerAo Huang, De-Zhen Guo, Xuan Zhang, et al.Eclinicalmedicine|July 7, 2023
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 studyXi Ding, Yi-Jun Hua, Xiong Zou, et al.Pageof 118